Professor Jean-Yves Blay, MD. is the Director of the European Reference Network on Adult Cancers – ERN EURACAN (Solid Tumours), Director General of the Centre Léon Bérard, the comprehensive cancer centre of Lyon and the Rhône-Alpes region, and an oncologist, researcher and medical oncologist professor at the University Claude Bernard, France. He focuses on sarcomata, targeted treatment of cancer, the biology of the breast carcinoma, and the relationship between tumour immunologic microenvironment and malignant cells, with the goal of clinical applications in the field of diagnosis, prognosis and treatment.
He has been distinguished with the Hamilton-Fairly award from ESMO (2012) and the Henry and Mary-Jane Mitjaville prize from the National Academy of Medicine (2013).
Professor Blay is the Subject Editor for Sarcoma and Gastrointestinal Stromal Tumors for the ESMO Guidelines Committee, and the Director of ERN-EURACAN, designated by the EU Commission in 2016 to improve the quality of care for patients with rare cancers in the European Union.
He is also the President of the French Sarcoma Group, the Network Leader of NETSARC sarcoma treatment reference centres, and a member of the ESMO EU Policy Committee and the ESMO Principles of Clinical Trials and Systematic Therapy Faculty. Previously, he served as the President of EORTC between 2009 and 2012 and the former Principal Investigator of Conticanet, an EU Commission network of research excellence. He is also a member of the scientific advisory board for Invivis Pharmaceutics Inc, Deciphera Pharmaceuticals LLC and Transgene SA.
Professor Blay has co-authored over 550 peer-reviewed articles and book chapters, advises various national and international institutions and research organisations, and is an active member of several oncological organisations and societies, such as ESMO, ASCO and AACR. He has been a member of the ESMO Open journal’s editorial board since 2016, and a reviewer for the Journal of Clinical Oncology, Blood, Cancer, Annals of Oncology and the European Journal of Cancer.